智通财经APP讯，泰格医药(300347.SZ)发布2025年第一季度报告，该公司营业收入为15.64亿元，同比减少5.79%。归属于上市公司股东的净利润为1.65亿元，同比减少29.61%。归属于上市公司股东的扣除非经常性损益的净利润为1.02亿元，同比减少66.23%。基本每股收益为0.19元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.